Eventzilla

27th Annual Controversies in the Management of the Patient with HIV

Friday, Nov 15, 2024 at 10:00 AM to 4:00 PM EST

1300 York Avenue, New York, New York, 10065, United States

Registration

Access code applied successfully. Remove

Invalid access code. Try again
Have an access code?

In-Person General Admission Partial Approval - $30.00

Sale ends on 11/15/2024

In-Person General Admission Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program, course materials and refreshments.

Virtual General Admission Partial Approval - $30.00

Sale ends on 11/15/2024

Virtual attendance via ZOOM registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials.

Enter your discount code

Subtotal (excluding fees and discounts)
Fee
Total amount

Event Information

Friday, Nov 15, 2024 at 10:00 AM to 4:00 PM EST

Uris Auditorium, 1300 York Avenue, New York, New York, 10065, United States.

Weill Cornell Medicine - Division of Infectious Diseases and the AIDS Education and Training Center (AETC) is proud to present our 27th Annual Controversies in the Management of the Patient with HIV.

This year's conference marks 27 years providing clinical education on HIV/AIDS. This year's program will cover the following topics:

Getting Better All the Time: Update on HIV Treatment
Advancing Towards ART- free remission and cure in perinatal HIV infection
Pre-exposure Prophylaxis (PrEP) Implementation: Current Advances, Challenges, and Opportunities
An Update on Kaposi Sarcoma
The Neglected Cousin: Update on HIV-2
Principals of Gender Affirming Care
Managing Agitation and Other Difficult Behaviors in HIV Care Settings

Target Audience: The conference is intended for primary care providers (internists, family care practitioners) and infectious disease and HIV specialists, including, physicians, nurse practitioners and physician assistants. Anyone who is interested in this program is welcome to attend.

*REGISTRATION FEE: $30 (Free for Residents, Fellows and Medical Students)

*Registration fee to be paid to Weill Cornell Medicine inclusive of: admission to program and course materials (lunch will be provided for in-person attendees).

CME/MOC Pending

Speakers

Learn more aboutMarshall Glesby, MD, PhD

Marshall Glesby, MD, PhD

Professor of Medicine and Population Health Sciences, Associate Chief, Division of Infectious Diseases

Weill Cornell Medicine

Dr. Glesby is a Professor of Medicine and Healthcare Policy and Research and Regional Director of the Northeast Caribbean AIDS Education and Training Center (AETC). Dr. Glesby trained in internal medicine and in infectious diseases at Johns Hopkins and received a Ph.D. in clinical investigation from the Johns Hopkins School of Hygiene and Public Health. His research interests include metabolic, cardiopulmonary, and aging-related complications in people living with HIV. He also collaborates with colleagues in Brazil on studies of HTLV-I infection and leishmaniasis. Dr. Glesby directs the HIV/AIDS Clinical Trials Unit at Weill Cornell and is the Director of the Clinical and Translational Research Unit Core of Weill Cornell Clinical and Translational Science Center.

Learn more aboutRoy Gulick, MD

Roy Gulick, MD

Rochelle Belfer Professor of Medicine Chief, Division of Infectious Diseases

Weill Cornell Medicine

Dr. Gulick is the Rochelle Belfer Professor in Medicine and Chief of the Division of Infectious Diseases at Weill Cornell Medicine. Dr. Gulick trained in internal medicine at Columbia and in infectious diseases at Harvard and received his MPH in clinical trial design from the Harvard School of Public Health. His research focuses on clinical trials of antiretroviral therapies for treatment and prevention of HIV infection. Dr. Gulick currently serves as Principal Investigator of the Weill Cornell Medical College-New Jersey Medical School Clinical Trials Unit of the NIH-sponsored AIDS Clinical Trials Group (ACTG). He also serves as Co-Chair of the U.S. Department of Health and Human Services Panel for Clinical Practices for Treatment of HIV Infection (DHHS Guidelines Panel), Chair of NIH Office of AIDS Research Advisory Committee (OARAC) and is a Board Member of the International Antiviral Society-USA. Current projects include evaluating treatment strategies for both antiretroviral therapy-naïve and experienced patients, and using antiretroviral therapy as a prevention strategy (PrEP, pre-exposure prophylaxis).

Learn more aboutSarit A. Golub, PhD, MPH

Sarit A. Golub, PhD, MPH

Distinguished Professor, Department of Psychology

Hunter College of the City University of New York

Sarit A. Golub, PhD, MPH, is Distinguished Professor of Psychology at Hunter College and the Graduate Center of the City University of New York (CUNY), and Co-Director of the Behavioral and Implementation Science Core of the Einstein-Rockefeller-CUNY Center for AIDS Research (ERC-CFAR). Dr. Golub is a behavioral scientist with interdisciplinary training in public health and implementation science. She received her MPH from the Columbia University Mailman School of Public Health and her PhD in Social Psychology from Harvard University. Dr. Golub directs the Hunter Alliance for Research & Translation (HART), whose mission is to translate research findings into practical implications for service and advocacy organizations, accelerating the pace of equitable, just, empirically-based practice. Dr. Golub conducts NIH and CDC-funded community-based implementation research, focusing on development and evaluation of novel strategies to decrease stigma, increase access, empower patients and improve sexual health.

Learn more aboutAyana E. Morales, MD, MS

Ayana E. Morales, MD, MS

Assistant Professor of Medicine, Division of Infectious Diseases

Weill Cornell Medicine

Ayana E. Morales, M.D. M.S., is an Assistant Professor of Medicine in the Division of Infectious Diseases at Weill Cornell. She completed her infectious diseases fellowship at Weill Cornell. Dr. Morales is conducting research under the mentorship of Dr. Ethel Cesarman on HIV associated malignancies, studying virus and host mechanisms of disease with a focus on HIV associated Kaposi Sarcoma. She has presented her work at both local and international meetings. She recently published her original research in PLOS Pathogens. She competed successfully for a KL2 in 2018 under the mentorship of Dr. Ethel Cesarman. She received a research Supplement on Dr. Ethel Cesarman’s R01 PQ6, “New Models of KSHV Oncogenesis and KS Immune Environment”. She is a protocol cochair of an AIDS Malignancy Consortium, Kaposi Sarcoma working group led clinical trial investigating Pomalidomide in the United States in participants with Kaposi Sarcoma and is working towards incorporating her original research to open a new AMC clinical trial investigating immunotherapies in patients with Kaposi sarcoma. Dr. Morales serves on the inpatient and outpatient services, providing care to patients in general infectious diseases.

Learn more aboutDeborah Persaud, MD

Deborah Persaud, MD

Professor of Pediatrics

Johns Hopkins University School of Medicine

Deborah Persaud, M.D. is a leading pediatric infectious diseases specialist and a renowned expert in pediatric HIV research. She is a Professor of Pediatrics at Johns Hopkins University School of Medicine and the Director of the Division of Pediatric infectious Diseases at the Johns Hopkins Children's Center. Dr. Persaud is internationally recognized for her groundbreaking work in the field of pediatric HIV, particularly her research on HIV remission and potential cures in infants. Her pioneering studies, including the well-known case of the "Mississippi baby," have significantly advanced our understanding of very early antiretroviral therapy and its role in achieving long-term remission in children born with HIV. Dr. Persaud has received numerous awards for her contributions to the field and continues to lead innovative research aimed at eradicating HIV in pediatric populations. She is the Co-Principal Investigator for the first NIH-sponsored Martin Delaney Collaboratory(MDC) focused on Pediatric HIV remission and cure-the-Pediatric Adolescent Virus Elimination (PAVE) MDC and the Scientific Chair for the HIV Cure and Immunotherapeutic Committee for the International Maternal Pediatric Adolescent AIDS Clinical trials Network.

Learn more aboutTamar Reisman, MD

Tamar Reisman, MD

Assistant Professor, Department of Medicine

Division of Endocrinology

Dr. Tamar Reisman is a general endocrinologist with a commitment to providing inclusive, high-quality care for LGBTQ+ individuals. She currently is a clinical endocrinologist at New York Presbyterian Weill Cornell Medical Center where she is Co-clinical lead of the Gender Affirming Care Program and Associate Program Director of the endocrinology fellowship. Her specific areas of expertise include transgender hormone therapy, sexual health throughout the lifespan, differences in sex development (DSD), and testosterone disorders. Dr. Reisman completed her Internal Medicine internship and residency at the University of Southern California in Los Angeles, and her Endocrinology, Diabetes, and Metabolism fellowship at UCLA’s David Geffen School of Medicine. She joins Weill Cornell Medicine from Mount Sinai's Center for Transgender Medicine and Surgery (CTMS) and the Icahn School of Medicine where she also served as Associate Program Director for the Endocrinology fellowship program.

Learn more aboutJames Satriano, PhD

James Satriano, PhD

Assistant Professor of Clinical Psychology

Columbia University Medical Center

Dr. James Satriano is a clinical psychologist and has been a faculty member of the Columbia University Behavioral Health Training Project since the inception of the program. He is currently an Assistant Clinical Professor in the department of Psychiatry at Columbia University, he is a research scientist at the New York State Psychiatric Institute, and former research associate at the Institute for Health, Health Care Policy, and Aging Research at Rutgers University. Dr. Satriano served as the Coordinator of Mental Health Services for the first HIV/AIDS Unit in the Veterans Administration Health Care System in the late 80s and he served as the Director of HIV/AIDS Programs for the New York State Office of Mental Health.

Learn more aboutPaul E. Sax, MD

Paul E. Sax, MD

Clinical Director of the Division of Infectious Diseases

Brigham and Women's Hospital

Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital and Professor of Medicine at Harvard Medical School. He holds the Bruce A. Beal and Robert L. Beal Distinguished Chair in Infectious Diseases. He received his MD from Harvard Medical School, did his residency in Internal Medicine at the Brigham, then fellowship in Infectious Diseases at Massachusetts General Hospital. Dr. Sax is the Editor-in-Chief of Clinical Infectious Diseases, the flagship journal of the Infectious Diseases Society of America (IDSA). In addition, he is a Section Editor of HIV/AIDS in UpToDate, and on the Editorial Board of NEJM Journal Watch, where he writes a regular column called HIV and ID Observations. An internationally recognized clinician and clinical teacher in infectious diseases and HIV, Dr. Sax also has been actively involved in research. Ongoing areas of investigation include clinical trials of antiretroviral therapies, cost-effectiveness of strategies for HIV management, and toxicity of antiretroviral therapy. He was closely involved in the clinical management and prevention of COVID-19, including frequent communications with the medical and lay public about the disease.

Event Schedule

Welcome
Register
Learning
Programming
Advantages
Workshop
Managemet
Programs
test
- test

10:00 AM